| Literature DB >> 33478082 |
Giulia Turri1, Valeria Barresi2, Alessandro Valdegamberi1, Gabriele Gecchele1, Cristian Conti1, Serena Ammendola2, Alfredo Guglielmi1, Aldo Scarpa2, Corrado Pedrazzani1.
Abstract
Although stage I and II colon cancers (CC) generally show a very good prognosis, a small proportion of these patients dies from recurrent disease. The identification of high-risk patients, who may benefit from adjuvant chemotherapy, becomes therefore essential. We retrospectively evaluated 107 cases of stage I (n = 28, 26.2%) and II (n = 79, 73.8%) CC for correlations among preoperative inflammatory markers, histopathological factors and long-term prognosis. A neutrophil-to-lymphocyte ratio greater than 3 (H-NLR) and a platelet-to-lymphocyte ratio greater than 150 (H-PLR) were significantly associated with the presence of poorly differentiated clusters (PDC) (p = 0.007 and p = 0.039, respectively). In addition, H-NLR and PDC proved to be significant and independent survival prognosticators for overall survival (OS; p = 0.007 and p < 0.001, respectively), while PDC was the only significant prognostic factor for cancer-specific survival (CSS; p < 0.001,). Finally, the combination of H-NLR and PDC allowed an optimal stratification of OS and CSS in our cohort, suggesting a potential role in clinical practice for the identification of high-risk patients with stage I and II CC.Entities:
Keywords: colon cancer; histopathological markers; immune system; inflammatory markers; poorly differentiated clusters; prognostic factors
Year: 2021 PMID: 33478082 PMCID: PMC7835814 DOI: 10.3390/biomedicines9010094
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059